ArticleAdvanced healthcare materials2025
Translational Extracellular Matrix Spray-Coating Approach for Large-Scale Bioactive Surface Functionalization and Tissue Repair.
Article in Advanced healthcare materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Adaptive Hyaluronic Acid Hydrogels for Regenerative Wound Healing: From Microenvironment Sensing to ECM Reprogramming and Precise Tissue Regeneration.Macromolecular rapid communications · 2026Review
- Smart Healing for Wound Repair: Emerging Multifunctional Strategies in Personalized Regenerative Medicine and Their Relevance to Orthopedics.Antibiotics (Basel, Switzerland) · 2026Review
- Translational Extracellular Matrix Spray-Coating Approach for Large-Scale Bioactive Surface Functionalization and Tissue Repair.Advanced healthcare materials · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
While various extracellular matrix (ECM)-based delivery platforms such as cell sheets, nanoparticles, and dressings have demonstrated potential for tissue repair, their clinical translation remains limited by poor scalability, structural fragility, and substrate-specific constraints. This study introduces a translational spray-coating strategy capable of conformationally activating ECM proteins, specifically fibronectin (FN) and collagen (COL), via mechanical unfolding during deposition. Using a commercially available airbrush, micrometer-scale droplets are uniformly deposited onto diverse biomedical substrates, including polydioxanone sutures and oxidized regenerated cellulose/collagen dressings, without structural damage. Notably, FN undergoes conformational changes that enhance cell adhesion, while multi-ECM sprays promote fibrillogenesis, directional matrix organization, and increase fibroblast migration and proliferation. In a full-thickness murine wound model, sequential ECM spraying results in a 88.2% wound closure rate and 66.6% COL density, outperforming both drop-treated and commercial control groups. These findings position ECM spray-coating as a scalable, bioactive platform for advanced wound therapy and surface functionalization in regenerative medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.